Replies to post #17919 on Ayala Pharmaceuticals Inc (ADXS)

[fbg0316]

Mastiff, you actually raise a good point - since Dan O'Connor took over it's only been traders/shorts (and management of course) who are above water. New investors who came in across the recapitalization of the company over the last four years at an average price of $12 are down, yet traders and shorts who contribute to the volatility of the stock have faired better. Why it is that? Considering the impressive progress of the company, it seems odd that only short-term traders, shorts and ADXS management have seen their financial position increase while long-term investors have taken it on the chin. You don't think that says something about the way the company is being run?

[deckheight]

I have been doing the exact opposite of what he says to do and it has been working out great! He is just like a reverse trading barometer...